InvestorsHub Logo
Followers 26
Posts 6769
Boards Moderated 5
Alias Born 03/20/2017

Re: None

Monday, 03/12/2018 9:09:21 AM

Monday, March 12, 2018 9:09:21 AM

Post# of 21475
Medical Cannabis Ltd in a exclusive veterinary medications program.

https://www.hempgazette.com/news/cannabis-veterinary-australia-mb0485/


JV with Algae Tech; We will exclusively license Medical Cannabis Limited’s low-THC cannabis cultivars with view to establishing a breeding program to identify strains suitable for use in developing medications for treating farm stock, other large stock and pets.


“It is the goal of AEB to be actively developing medical cannabis products for animal use in 2018 and to be the leaders and at the forefront in supplying the huge local and global animal industry with these unique products,” says part of a statement from QBL. “There is a massive demand in the animal industry for suitable and safe drugs for the transport and general treatment of animals whether for anxiety or pain related problems.”


The results from the veterinary related research could also provide a springboard for relevant human studies.
The arrangement will see Medical Cannabis Limited issued shares in AEB, giving MCL a 19.99% shareholder stake in the company.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.